Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 32.34 billion as of December 5, 2025. Its market cap has decreased by -43.80% in one year.

Market Cap

32.34B

Enterprise Value

31.52B

Revenue

42.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

192.00

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 32.34B, an increase of 653.09%. That is a compound annual growth rate of 21.43%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	32.34B	-23.40%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	258.22B
PharmaEssentia	191.95B
Lotus Pharmaceutical	78.89B
Bora Pharmaceuticals Co., LTD.	65.31B
Lin BioScience	33.46B
Oneness Biotech	32.96B
Center Laboratories	27.88B
Pegavision	23.79B

Market Cap Rankings